NEW YORK, Dec. 3 – French genomics company ExonHit Therapeutics said Monday it raised 30 million euros ($26.8 million) in a third round of private financing.

The Paris-based company, which develops therapeutics and diagnostics based on the analysis of alternative splicing events, said that Dresdner Kleinwort Capital of the UK, Danske Bank of Denmark, and France’s LCF E. de Rothschild and Sudinnova participated in the financing round. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.